SCHEMBL8871052

SCHEMBL8871052

COC(=O)C1=C(C)N(C)C(C)=C(C(C)=O)C1c1cccc([N+](=O)[O-])c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.61
CYP1A2 P05177 3/20 0.61
CYP3A4 P08684 3/20 0.61
CYP2C9 P11712 3/20 0.61
CYP2C19 P33261 3/20 0.61
MAPT P10636 3/20 0.61
NPSR1 Q6W5P4 2/20 0.61
CYP2D6 P10635 2/20 0.61
NFKB1 P19838 2/20 0.61
LMNA P02545 2/20 0.61
GMNN O75496 1/20 0.61
BLM P54132 1/20 0.61
PMP22 Q01453 1/20 0.61
HIF1A Q16665 3/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
POLB P06746 1/20 0.59
MAPK1 P28482 1/20 0.59
GPR55 Q9Y2T6 1/20 0.59
THPO P40225 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16189736 0.95 TSHR (0.66) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL11681591 0.91 MAPT (0.61) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL31191654 0.91 MAPT (0.61) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL11802487 0.89 NR1I2 (0.65) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL10731971 0.89 CYP1A2 (0.76) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL11809510 0.86 MEN1 (0.65) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL10652739 0.86 CYP1A2 (0.66) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL8440174 0.86 TSHR (0.61) TSHRMAPTNPSR1LMNAMEN1
SCHEMBL11435536 0.85 MAPT (0.63) TSHRCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL10651685 0.85 CYP1A2 (0.62) TSHRCYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5646166-A POTASSIUM CHANNEL MODULATORS, TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 1997-07-08 US claimed
US-3966948-A Spasmolytic, vaso-dilating and anti-hypertensive compositions and methods BAYER AKTIENGESELLSCHAFT (DT) 1976-06-29 US claimed
US-3966948-A Spasmolytic, vaso-dilating and anti-hypertensive compositions and methods BAYER AKTIENGESELLSCHAFT (DT) 1976-06-29 US disclosed